Seqirus
- Biotech or pharma, therapeutic R&D
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular, renal, immunoglobulin and metabolic, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and genetic medicines to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
Our parent company, CSL, headquartered in Melbourne, Australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}